Molecular mechanisms of ferroptosis and its role in cancer therapy

Tao Xu1,2, Wei Ding3, Xiaoyu Ji1

  • 1School of Basic Medical Sciences, Qingdao University, Qingdao, China.

Insights

Ferroptosis, a form of programmed cell death involving iron-dependent lipid peroxidation, is a promising cancer therapy target. This review explores ferroptosis mechanisms, inducers, and cancer-specific sensitivities, highlighting unanswered questions.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is a distinct programmed cell death characterized by iron-dependent lipid peroxide accumulation.
  • First described in 2012, it possesses unique morphological and bioenergetic properties.
  • Its physiological roles in development are underexplored, but it shows significant therapeutic potential in cancer.

Purpose of the Study:

  • To review the molecular mechanisms underlying ferroptosis.
  • To discuss small molecules that initiate ferroptosis.
  • To examine ferroptosis sensitivity across various cancer types.

Main Methods:

  • Literature review focusing on ferroptosis research.
  • Analysis of molecular pathways involved in ferroptosis.
  • Compilation of data on ferroptosis inducers and cancer sensitivity.

Main Results:

  • Detailed overview of ferroptosis molecular mechanisms.
  • Identification of key small molecules (e.g., erastin, RSL3) that trigger ferroptosis.
  • Discussion of differential ferroptosis sensitivity in various cancers.

Conclusions:

  • Ferroptosis is a critical area of research with significant implications for cancer therapy.
  • Further investigation into its mechanisms and therapeutic applications is warranted.
  • Unanswered questions remain regarding ferroptosis's role and manipulation in cancer.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K